Unresectable Malignant Gastrointestinal Stromal Tumor: Clinical Trials

2 trials for Unresectable Malignant Gastrointestinal Stromal Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Not yet recruiting 1

Follow Unresectable Malignant Gastrointestinal Stromal Tumor: new trials by email Literature Review of Unresectable Malignant Gastrointestinal Stromal Tumor trials Research Report on Unresectable Malignant Gastrointestinal Stromal Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery
Ipilimumab, Laboratory Biomarker Analysis, Nivolumab - Locally Advanced Bone Sarcoma, Locally Advanced Dedifferentiated Liposarcoma
Phase 2CompletedNational Cancer Institute (NCI)1642015-08-132023-10-17

Narrower conditions

Bone Neoplasms (1)  ·  Gastrointestinal Stromal Tumors (1)  ·  Histiocytoma, Malignant Fibrous (1)  ·  Liposarcoma (1)  ·  Sarcoma (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective Tissue (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Bone Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Histiocytoma (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Adipose Tissue (1)  ·  Neoplasms, Fibrous Tissue (1)

Interventions

CTLA-4 Antigen (1)  ·  Cyclophosphamide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Ipilimumab (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Nivolumab (1)  ·  Specimen Handling (1)  ·  Surgical Procedures, Operative (1)  ·  X-Rays (1)  ·  aldesleukin (1)  ·  fludarabine (1)

Sponsors

Joal Beane (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)

Top investigators

Joal Beane, MD (1)  ·  Sandra P D'Angelo (1)

Results publications

PMID 29370992, PMID 39343511

NIH funding

U10CA180821 (1)